Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 09:30AM ET
34.03
Dollar change
-0.33
Percentage change
-0.95
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y16.24% Shs Outstand Perf Week-3.11%
SponsorPacer Financial ETF Type Tagsequity Return% 3Y4.90% Total Holdings54 Perf Month-4.59%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM3.41M Perf Quarter4.13%
IndexLifeSci BioThreat Strategy Index Average Maturity Tagspharmaceutical Return% 10Y NAV% Perf Half Y14.52%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year15.76%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range27.71 - 36.26 Perf YTD5.31%
Dividend TTM0.25 (0.73%) ESG Type Tags- Flows% 3M-19.44% 52W High-6.16% Beta0.86
Dividend Ex-DateMar 21, 2024 Dividend Type Sector/Theme Flows% YTD-0.46% 52W Low22.79% ATR (14)0.24
Expense0.70% Structure Type Region Flows% 1Y RSI (14)29.73 Volatility0.30% 0.08%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.01 Prev Close34.36
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.10K Price34.03
SMA20-4.27% SMA50-2.99% SMA2006.70% Trades Volume1 Change-0.95%
Jan-21-22 11:30AM
Aug-25-21 12:00PM
Pacer BioThreat Strategy ETF seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index (the "index"). The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.